Sarepta Therapeutics (SRPT) Treasury Shares (2010 - 2026)

Sarepta Therapeutics (SRPT) posted quarterly Treasury Shares of $655642.0 for Q1 2026, up 0.73% quarter-over-quarter from $650876.0 in Q4 2025.

Sarepta Therapeutics (SRPT) Treasury Shares (2010 - 2026) Analysis & Trends

Sarepta Therapeutics' Treasury Shares history runs 16 years deep, the most recent figure standing at $655642.0 for Q1 2026.

In Q1 2026, Treasury Shares changed N/A year-over-year to $655642.0; the TTM figure through Mar 2026 stood at $655642.0 (changed N/A YoY), while the FY2025 annual figure was $650876.0, up 15.46% from the prior year.
Treasury Shares for Q1 2026 stood at $25.3 million, roughly flat from $25.3 million in the prior quarter.
The five-year high for Treasury Shares was $2.2 million in Q4 2023, with the low at -$651000.0 in Q2 2025.
The 4-year median for Treasury Shares is $653259.0 (2025), against an average of $896088.3.
The sharpest annual moves came in 2022 and 2023: Treasury Shares surged 38.59% in 2022, then climbed 22.46% in 2023.
Sarepta Therapeutics' Treasury Shares stood at $25.3 million in 2025, then changed by 0.0% to $25.3 million in 2026.
Business Quant data shows SRPT's Treasury Shares at $25.3 million in Q1 2026, $25.3 million in Q4 2025, and $25.3 million in Q3 2025.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Treasury Shares (Qtr)
1	Vertex Pharmaceuticals	128.13 Bn	120.28 Bn	2.84 Bn	-
2	Regeneron Pharmaceuticals	112.33 Bn	104.33 Bn	3.93 Bn	36.40 Mn
3	Argenx Se	53.24 Bn	48.05 Bn	1.41 Bn	-
4	Revolution Medicines	43.64 Bn	43.64 Bn	-	5.08 Mn
5	BeOne Medicines	39.27 Bn	34.17 Bn	1.53 Bn	-
6	MindWalk Holdings	35.32 Bn	35.31 Bn	1.82 Bn	-
7	Royalty Pharma	33.72 Bn	35.84 Bn	-	2.72 Mn
8	Alnylam Pharmaceuticals	30.58 Bn	27.27 Bn	992.69 Mn	-
9	Insmed	27.01 Bn	25.85 Bn	358.27 Mn	92,219.00
10	Sarepta Therapeutics	1.91 Bn	1.12 Bn	251.87 Mn	655,642.00

Download Data